SCHEMBL2019256

SCHEMBL2019256

Cc1nc(CCNc2ncnc3[nH]cnc23)c(-c2cccc(F)c2)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 6/20 0.42
PIK3CD O00329 9/20 0.40
PIK3CG P48736 1/20 0.39
SYK P43405 1/20 0.39
LMNA P02545 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDR P35968 2/20 0.35
GBA1 P04062 1/20 0.35
MET P08581 1/20 0.35
TP53 P04637 1/20 0.35
AURKA O14965 1/20 0.34
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016100 0.86 MAP4K4 (0.40) MAP4K4PIK3CDPIK3CGSYKLMNA
SCHEMBL2015901 0.81 MAPK1 (0.48) MAP4K4PIK3CDPIK3CGSYKLMNA
SCHEMBL2051140 0.81 PIK3CD (0.45) MAP4K4PIK3CDPIK3CGSYKLMNA
SCHEMBL2014889 0.79 PIK3CD (0.49) MAP4K4PIK3CDPIK3CG
SCHEMBL2014148 0.79 PIK3CD (0.47) MAP4K4PIK3CDPIK3CGSYKLMNA
SCHEMBL17165550 0.78 PIK3CD (0.56) PIK3CDPIK3CG
Hydrochloric Acid SCHEMBL18228629 0.77 PIK3CD (0.55) PIK3CDPIK3CG
SCHEMBL2714343 0.77 PIK3CD (0.53) MAP4K4PIK3CDPIK3CG
SCHEMBL2014851 0.76 PIK3CD (0.46) MAP4K4PIK3CDPIK3CGSYKLMNA
SCHEMBL8573 0.76 PIK3CD (0.54) MAP4K4PIK3CDPIK3CGSYKLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed